SCHEMBL29721948

SCHEMBL29721948

Cc1cccc(-c2ncc3c(n2)N(c2ccncc2C#N)CC(=O)N3C)n1

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 2/20 0.35
▸ CYP2A6 P11509 1/20 0.34
▸ TGFBR1 P36897 9/20 0.34
▸ FNTA P49354 1/20 0.33
▸ FNTB P49356 1/20 0.33
▸ PGGT1B P53609 1/20 0.33
▸ TGFBR2 P37173 3/20 0.32
▸ CYP11B1 P15538 2/20 0.31
▸ CYP11B2 P19099 2/20 0.31
▸ PIK3R1 P27986 1/20 0.31
▸ ADORA2A P29274 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ STK4 Q13043 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ PARP1 P09874 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29722220 0.84 TGFBR1 (0.37) PIK3CDCYP2A6TGFBR1TGFBR2PIK3R1
SCHEMBL29721902 0.82 TGFBR1 (0.38) CYP2A6TGFBR1TGFBR2
SCHEMBL29722090 0.80 TGFBR1 (0.40) TGFBR1TGFBR2
SCHEMBL29722172 0.79 TGFBR1 (0.35) PIK3CDCYP2A6TGFBR1CYP11B2PIK3R1
SCHEMBL29722118 0.79 SCN9A (0.38) PIK3CDCYP2A6TGFBR1TGFBR2
SCHEMBL28734418 0.78 PIK3CD (0.36) PIK3CDCYP2A6TGFBR1TGFBR2STK4
SCHEMBL28734453 0.78 TGFBR1 (0.36) CYP2A6TGFBR1TGFBR2ADORA2AADORA1
SCHEMBL28734414 0.78 TGFBR1 (0.41) TGFBR1TGFBR2STK4
SCHEMBL29722165 0.78 PIK3CD (0.36) PIK3CDCYP2A6TGFBR1TGFBR2STK4
SCHEMBL29722203 0.78 TGFBR1 (0.34) PIK3CDCYP2A6TGFBR1CYP11B2PIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114380845-A Heterocyclic-fused compound, pharmaceutical composition containing same, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2022-04-22 — — CN disclosed
Send feedback